title: Molecular characteristics of pediatric high-grade gliomas.
abstract: High-grade gliomas (HGGs) are extremely lethal tumors. Survival has not changed significantly in the past decades. The only known prognostic factors in pediatric HGGs (pHGGs) are extent of resection and histologic grade. Treatment has historically been based on adult trials because of the rarity of pHGGs and the lack of genomic tools to explore their unique molecular characteristics. The recent advances in molecular biological data helped divide these tumors into distinct subgroups. In this review, the authors focus on major molecular targets of alterations in pHGGs: histone H3.3, telomeres, PDGFRA, IDH, BRAF (V600E), ACVR1 and NTRK and briefly highlight the difference with the adult counterpart.
authors.affiliation: Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
authors.forename: Omar
authors.initials: O
authors.lastname: Chamdine
authors.forename: Amar
authors.initials: A
authors.lastname: Gajjar
mesh_terms: D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics* / Q000628:therapy; D002648:Child; D005910:Glioma / Q000145:classification / Q000235:genetics* / Q000628:therapy; D006801:Humans; D060787:Neoplasm Grading
keywords: epigenetics; high-grade glioma; histone; molecular biology; pediatric